Grant: CIHR - ICR / Cancer Research Society Partnership - Research Grants
University of Alberta
$60,000.00
Rab32 Promotes Autophagic Elimination of a Metabolism Control Center in Breast Cancer
EF 2020-21
Résumé
The investigation of tumor tissue weaknesses over the past 20 years has identified their energy and biomass production as a characteristic. During the transformation of normal into cancer tissue, the cells change their metabolic properties drastically. They first interweave sugar and oxygen consumption reactions to increase the production of cellular building blocks and when a tumor reaches critical mass, they are able to completely eliminate oxygen consumption, while still allowing growth. Our research aims to understand the mechanisms that change these key properties of cancer cells. We have identified the protein Rab32 behind such changes. Rab32 is specifically induced in aggressive breast cancer cells. Patients with high levels of this protein have a poor prognosis. We have scanned all known biological pathways controlled by Rab32 and have identified a mechanism called autophagy that cooperates with Rab32 to decrease patient survival. The autophagy type triggered by Rab32 specifically alters how cells use sugar and oxygen. Therefore, we postulate that Rab32 is a protein that gives cancer cells the ability to switch their metabolism. With the present proposal we will investigate how Rab32 achieves this goal. The information generated by our research will be used in the future to attack metabolic changes of tumor tissue therapeutically.
Programme
CIHR - ICR / Cancer Research Society Partnership - Research Grants
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
453484
Name
Simmen Thomas
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Cancer Research Society Inc.; Cancer Research Society Inc.
Instname2
Cancer Research
Prcname2
Special Cases
Projecttitle
Rab32 Promotes Autophagic Elimination of a Metabolism Control Center in Breast Cancer
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$60,000
Cihrequipment2
$0
Programname2
CIHR - ICR / Cancer Research Society Partnership - Research Grants
Keyworddelim
Oncogenes; Supressors; Tumour
Abstract
The investigation of tumor tissue weaknesses over the past 20 years has identified their energy and biomass production as a characteristic. During the transformation of normal into cancer tissue, the cells change their metabolic properties drastically. They first interweave sugar and oxygen consumption reactions to increase the production of cellular building blocks and when a tumor reaches critical mass, they are able to completely eliminate oxygen consumption, while still allowing growth. Our research aims to understand the mechanisms that change these key properties of cancer cells. We have identified the protein Rab32 behind such changes. Rab32 is specifically induced in aggressive breast cancer cells. Patients with high levels of this protein have a poor prognosis. We have scanned all known biological pathways controlled by Rab32 and have identified a mechanism called autophagy that cooperates with Rab32 to decrease patient survival. The autophagy type triggered by Rab32 specifically alters how cells use sugar and oxygen. Therefore, we postulate that Rab32 is a protein that gives cancer cells the ability to switch their metabolism. With the present proposal we will investigate how Rab32 achieves this goal. The information generated by our research will be used in the future to attack metabolic changes of tumor tissue therapeutically.
Competitiondate
202103
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Simmen, Thomas
Approvedterm
2 ans 0 mois
Cihrcontribution2
Breast Cancer Initiative~ $60,000~ $0~